We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study of VEGF-Antisense Oligonucleotide in Combination With Pemetrexed and Cisplatin for the Treatment of Advanced Malignant Mesothelioma

This study has been withdrawn prior to enrollment.
(Sponsor withdrew support)
Sponsor:
ClinicalTrials.gov Identifier:
NCT00668499
First Posted: April 29, 2008
Last Update Posted: May 21, 2014
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Sponsor Name Pending
Information provided by:
University of Southern California
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Estimated Study Completion Date: April 2011
  Estimated Primary Completion Date: April 2011 (Final data collection date for primary outcome measure)